echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Zhejiang Pharmaceutical Ninofloxacin Malate Sodium Chloride Injection Obtained Drug Registration Certificate

    Zhejiang Pharmaceutical Ninofloxacin Malate Sodium Chloride Injection Obtained Drug Registration Certificate

    • Last Update: 2021-08-12
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On June 21, Zhejiang Medicine announced that it had recently received the "Drug Registration Certificate" approved and issued by the National Medical Products Administration for nanoxacin malate sodium chloride injection 250ml:0.


    Nenoxacin is a new type of non-fluoroquinolone antibiotic, used to treat Streptococcus pneumoniae, Staphylococcus aureus, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis, Klebsiella pneumoniae and Mycoplasma pneumoniae, Chlamydia pneumoniae and Legionella pneumophila caused mild to moderate adult (≥18 years) community-acquired pneumonia


    It is understood that up to now, Zhejiang Pharmaceutical has invested about 7 million yuan in research and development expenses for the development of nanofloxacin malate sodium chloride injection project (not including the technology transfer fee of Taiwan Taijing)


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.